scispace - formally typeset
Open AccessJournal ArticleDOI

Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.

Reads0
Chats0
TLDR
Human interferon-alpha 2 interacted additively or synergistically with rimantadine hydrochloride or ribavirin in reducing the yield of clinical isolates of either H3N2 or H1N1 subtype influenza A viruses and inhibited the replication of an influenza B virus to a greater extent than either single agent.
Abstract
Recombinant DNA-produced human interferon-alpha 2 inhibited the replication of influenza A and B viruses in primary rhesus monkey kidney cells (RMK). Human interferon-alpha 2 interacted additively or synergistically with rimantadine hydrochloride or ribavirin in reducing the yield of clinical isolates of either H3N2 or H1N1 subtype influenza A viruses. The combination of human interferon-alpha 2 and ribavirin also inhibited the replication of an influenza B virus to a greater extent than either single agent. In addition to drug concentration, the virus inoculum and duration of culture were important variables in determining the degree of inhibition. Single drugs or combinations did not significantly inhibit the growth of uninfected RMK cells, which indicated that the observed interactions with respect to antiviral activity were not due to cell cytotoxicity.

read more

Citations
More filters
Journal ArticleDOI

Antiviral agents active against influenza A viruses

TL;DR: This article reviews agents that have been shown to have activity against influenza A viruses and discusses their therapeutic potential, and also describes emerging strategies for targeting these viruses.
Journal ArticleDOI

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C

TL;DR: Findings suggest that ribavirin plus IFN-alpha combination therapy is able to induce a sustained biochemical and virological response in a significant proportion of patients with IFn-alpha-resistant chronic hepatitis C.
Journal ArticleDOI

Influenza virus resistance to neuraminidase inhibitors.

TL;DR: The mechanism of action, pharmacokinetics and clinical indications of neuraminidase inhibitors (NAIs) with an emphasis on the emergence of antiviral drug resistance are reviewed.
Journal ArticleDOI

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

TL;DR: The combination of IFN‐α and ribavirin is effective in reducing HCV‐RNA levels and ameliorating hepatocellular injury in recurrent HCV after liver transplantation, and that maintenance therapy with ribaviri monotherapy can maintain the biochemical and histological response.
Journal ArticleDOI

Developing new antiviral agents for influenza treatment: what does the future hold?

TL;DR: Combination therapy with currently available agents is supported by data from animal models but has received limited clinical study to date.
References
More filters
Journal ArticleDOI

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

TL;DR: Rimantadine appears to be the drug of choice for the prophylaxis of influenza A, as compared with placebo in a placebo-controlled, double-blind, randomized trial.
Journal ArticleDOI

Plaque inhibition assay for drug susceptibility testing of influenza viruses.

TL;DR: This assay proved to be a reliable, rapid method of determining 50% inhibitory concentrations that correlated well with clinically achievable drug levels and the results of clinical trials.
Journal ArticleDOI

Ribavirin small-particle aerosol treatment of influenza

TL;DR: In an outbreak of influenza virus A/England/333/80(H1N1) infections in college students, 14 randomly selected patients were treated by inhalation of ribavirin small-particle aerosol through a face mask to achieve a therapeutic effect.
Journal ArticleDOI

Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

TL;DR: During an influenza outbreak, five days of empirical therapy with amantadine or rimantadines for persons with an influenza-like syndrome should ameliorate clinical symptoms and might decrease spread of virus.
Journal ArticleDOI

Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

TL;DR: Combinations with these antivirals, which are currently being evaluated singly for the therapy of severe forms of herpetic infection, could prove clinically useful if increasing numbers of resistant viral strains are observed.
Related Papers (5)